525 related articles for article (PubMed ID: 38045830)
21. Biomarkers for predicting efficacy of PD-1/PD-L1 inhibitors.
Yi M; Jiao D; Xu H; Liu Q; Zhao W; Han X; Wu K
Mol Cancer; 2018 Aug; 17(1):129. PubMed ID: 30139382
[TBL] [Abstract][Full Text] [Related]
22. Integrating Circulating Biomarkers in the Immune Checkpoint Inhibitor Treatment in Lung Cancer.
Duchemann B; Remon J; Naigeon M; Mezquita L; Ferrara R; Cassard L; Jouniaux JM; Boselli L; Grivel J; Auclin E; Desnoyer A; Besse B; Chaput N
Cancers (Basel); 2020 Dec; 12(12):. PubMed ID: 33287347
[TBL] [Abstract][Full Text] [Related]
23. Three‑dimensional models to study breast cancer (Review).
Huerta-Reyes M; Aguilar-Rojas A
Int J Oncol; 2021 Mar; 58(3):331-343. PubMed ID: 33650654
[TBL] [Abstract][Full Text] [Related]
24. Increased glycolysis correlates with elevated immune activity in tumor immune microenvironment.
Jiang Z; Liu Z; Li M; Chen C; Wang X
EBioMedicine; 2019 Apr; 42():431-442. PubMed ID: 30935888
[TBL] [Abstract][Full Text] [Related]
25. Tumor organoids: synergistic applications, current challenges, and future prospects in cancer therapy.
Qu J; Kalyani FS; Liu L; Cheng T; Chen L
Cancer Commun (Lond); 2021 Dec; 41(12):1331-1353. PubMed ID: 34713636
[TBL] [Abstract][Full Text] [Related]
26. Immune Biomarkers in Triple-Negative Breast Cancer: Improving the Predictivity of Current Testing Methods.
Porta FM; Sajjadi E; Venetis K; Frascarelli C; Cursano G; Guerini-Rocco E; Fusco N; Ivanova M
J Pers Med; 2023 Jul; 13(7):. PubMed ID: 37511789
[TBL] [Abstract][Full Text] [Related]
27. Mimicking tumor microenvironment by 3D bioprinting: 3D cancer modeling.
Shukla P; Yeleswarapu S; Heinrich MA; Prakash J; Pati F
Biofabrication; 2022 May; 14(3):. PubMed ID: 35512666
[TBL] [Abstract][Full Text] [Related]
28. PD-L1 expression in colorectal cancer is associated with microsatellite instability, BRAF mutation, medullary morphology and cytotoxic tumor-infiltrating lymphocytes.
Rosenbaum MW; Bledsoe JR; Morales-Oyarvide V; Huynh TG; Mino-Kenudson M
Mod Pathol; 2016 Sep; 29(9):1104-12. PubMed ID: 27198569
[TBL] [Abstract][Full Text] [Related]
29. Stromal PD-L1-Positive Regulatory T cells and PD-1-Positive CD8-Positive T cells Define the Response of Different Subsets of Non-Small Cell Lung Cancer to PD-1/PD-L1 Blockade Immunotherapy.
Wu SP; Liao RQ; Tu HY; Wang WJ; Dong ZY; Huang SM; Guo WB; Gou LY; Sun HW; Zhang Q; Xie Z; Yan LX; Su J; Yang JJ; Zhong WZ; Zhang XC; Wu YL
J Thorac Oncol; 2018 Apr; 13(4):521-532. PubMed ID: 29269008
[TBL] [Abstract][Full Text] [Related]
30. Tumor immune microenvironment and systemic response in breast cancer.
Kawaguchi K; Maeshima Y; Toi M
Med Oncol; 2022 Sep; 39(12):208. PubMed ID: 36175677
[TBL] [Abstract][Full Text] [Related]
31. In Vitro Veritas: From 2D Cultures to Organ-on-a-Chip Models to Study Immunogenic Cell Death in the Tumor Microenvironment.
Krysko DV; Demuynck R; Efimova I; Naessens F; Krysko O; Catanzaro E
Cells; 2022 Nov; 11(22):. PubMed ID: 36429133
[TBL] [Abstract][Full Text] [Related]
32. Emerging role of immunotherapy in urothelial carcinoma-Immunobiology/biomarkers.
Sweis RF; Galsky MD
Urol Oncol; 2016 Dec; 34(12):556-565. PubMed ID: 27836246
[TBL] [Abstract][Full Text] [Related]
33. Status of Immune Oncology: Challenges and Opportunities.
Cesano A; Marincola FM; Thurin M
Methods Mol Biol; 2020; 2055():3-21. PubMed ID: 31502145
[TBL] [Abstract][Full Text] [Related]
34. Tumor-Infiltrating Lymphocytes in Colorectal Cancer: The Fundamental Indication and Application on Immunotherapy.
Bai Z; Zhou Y; Ye Z; Xiong J; Lan H; Wang F
Front Immunol; 2021; 12():808964. PubMed ID: 35095898
[TBL] [Abstract][Full Text] [Related]
35. 3D Printing Techniques and Their Applications to Organ-on-a-Chip Platforms: A Systematic Review.
Carvalho V; Gonçalves I; Lage T; Rodrigues RO; Minas G; Teixeira SFCF; Moita AS; Hori T; Kaji H; Lima RA
Sensors (Basel); 2021 May; 21(9):. PubMed ID: 34068811
[TBL] [Abstract][Full Text] [Related]
36. Animal models for studying tumor microenvironment (TME) and resistance to lymphocytic infiltration.
Yamaguchi R; Perkins G
Cancer Biol Ther; 2018; 19(9):745-754. PubMed ID: 29723108
[TBL] [Abstract][Full Text] [Related]
37. Predictive Biomarkers for Immunotherapy in Gastric Cancer: Current Status and Emerging Prospects.
Hou W; Zhao Y; Zhu H
Int J Mol Sci; 2023 Oct; 24(20):. PubMed ID: 37895000
[TBL] [Abstract][Full Text] [Related]
38.
Li M; Ma Y; Zhong Y; Liu Q; Chen C; Qiang L; Wang X
J Immunother Cancer; 2020 Oct; 8(2):. PubMed ID: 33037113
[TBL] [Abstract][Full Text] [Related]
39. Design of spherically structured 3D in vitro tumor models -Advances and prospects.
Ferreira LP; Gaspar VM; Mano JF
Acta Biomater; 2018 Jul; 75():11-34. PubMed ID: 29803007
[TBL] [Abstract][Full Text] [Related]
40. The Three-Dimensional In Vitro Cell Culture Models in the Study of Oral Cancer Immune Microenvironment.
Dalir Abdolahinia E; Han X
Cancers (Basel); 2023 Aug; 15(17):. PubMed ID: 37686542
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
